Business inquiries

We'll email you back within 24 hours.

Get in touch

General inquiries

For member enquiries, public data requests, or general questions.

Contact usor visit Member helpdesk

Panel Members

Take surveys and earn points as a member of the YouGov panel.

Sign inRegister as a member

Business

Access YouGov products and services as a business.

Sign inRegister as a client
Search icon
Should pharmaceutical companies be required to license COVID‑19 treatments to generic drug makers? Published on November 19, 2021 → Survey conducted on November 19, 2021 on 4776 U.S. adults
42%
19%
39%
By:
42%
19%
39%
Related topics

Published on the same day

Which of the following comes closest to your view about COVID-19 vaccines' effect on the chance of getting infected?

See results

How many Thanksgiving celebrations will you attend this year?

See results

Explore more opinion data

Sector favorability: Pharmaceuticals & biotech

Tracker

Forever young? U.S. anti-aging report 2026

Article

Spring allergy season is underway and it’s reshaping the OTC aisle

Article

Brand pain points: Tracking Tylenol’s consumer performance through a turbulent year

Article

How fitness brands can reach weight-management-focused consumers in the US

Article

How Americans buy hair care – Three key insights brands need to know

Article

Where beauty ads land: the channels regular make-up users in the U.S. notice this holiday season

Article

Half of Americans believe aliens have visited Earth

Article

Younger Americans grow more doubtful of health insurers’ value for money

Article